Literature DB >> 12411753

Management of lupus nephropathy.

Lee A Hebert1.   

Abstract

This review is an evidence- and experience-based approach to the management of SLE, particularly its kidney manifestations. Specific protocols in substantial clinical detail are provided for management and monitoring, according to the severity of the SLE manifestations. The protocols are adapted from those used in a major SLE trial. The adaptations are based on subsequent extensive clinical use of these protocols. Also described is the concomitant use of cardio- and kidney-protective therapies to optimize patient outcomes. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12411753     DOI: 10.1159/000066645

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  2 in total

1.  Rapidly-progressive glomerulonephritis in a patient with Behcet's disease: successful treatment with intravenous cyclophosphamide.

Authors:  Sung-Dong Kim; Sang-Hyon Kim; Hae-Rim Kim; Chong-Hyeon Yoon; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  Rheumatol Int       Date:  2005-06-29       Impact factor: 2.631

2.  Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option.

Authors:  Alison McKinley; Edward Park; Dan Spetie; Kevin V Hackshaw; Smitha Nagaraja; Lee A Hebert; Brad H Rovin
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 8.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.